Mounjaro®
Starting from £179.99/mo
Start journey Learn moreIf you've started Mounjaro, or you're thinking about it, and you're not quite sure where to go with your questions, you're not alone. Mounjaro is a prescription-only tirzepatide injection that works on two gut-hormone receptors (GIP and GLP-1) to reduce appetite and support weight loss in clinically eligible adults. It's a powerful medicine, and most people find they have real questions after their first pen arrives. The right help depends on what you're asking: some things belong with your prescriber, some are answered by the Patient Information Leaflet, and some are simply part of getting used to a new routine. This page maps that out honestly, so you know exactly where to turn.
At your door the next working day.
Free, tracked, plain packaging.
BMI isn't the whole story, but it's where clinicians start. Check yours in ten seconds — nothing is stored, nothing is shared.
Ten seconds. Private — nothing is stored or shared.
Your result updates live in the card alongside.
Your result
Your BMI is
—
which is in the healthy weight range
Start journeyBMI doesn't determine eligibility — only a clinician can assess whether treatment is right for you.
The problem
The nume way
clinician review. Free next working day delivery.
How it works
Tell us about your health, history and goals. Free, online, and confidential — no commitment, no waiting room.
Our team reviews your health the same day — never an algorithm, and approves your treatment there and then if eligible.
Order by 12pm, dispatched same day, delivered free the next working day — the nume Promise.
The first week or two on Mounjaro can feel unsettling. Nausea after the injection, a sharply reduced appetite, some fatigue, patients often message us wondering whether something has gone wrong. In most cases, nothing has. The 2.5 mg starting dose exists specifically to let your body adjust before the dose increases; it's low enough that many people feel little effect at all beyond the early GI niggles. Those niggles (nausea, burping, a heavy feeling after eating) are the immune system's equivalent of getting used to a new pair of shoes. They're real, they're common, and for most people they ease within a few days to two weeks at each level.
The NHS medicines page for tirzepatide lists the common side effects clearly and is a reliable first stop for reassurance. If a symptom feels out of proportion (severe, persistent stomach pain that moves into your back, for instance) that's a different matter and needs urgent medical attention, not a web search. The MHRA flagged acute pancreatitis as an infrequent but serious risk for GLP-1 medicines in a January 2026 Drug Safety Update; it's rare, but it's the reason "call 111 or your GP" is the right answer for pain that won't shift, rather than waiting it out.
For anything that sits in the middle (uncomfortable but not alarming) your prescriber is the right call. At nume, our clinical team is available for aftercare seven days a week, so you don't have to wait until Monday to ask.
Some of the most common searches around Mounjaro help are questions that genuinely require a clinician's eye on your specific situation. Whether your next dose increase is right for you. Whether you should skip a pen because of illness. Whether a medication you take alongside Mounjaro needs adjusting. These aren't questions where a general answer is safe, the right response depends on your weight, your health history, your current dose and how you're tolerating it.
One area that surprises people is the interaction with oral contraceptives. Because Mounjaro slows gastric emptying, pill absorption can be affected, particularly in the first four weeks of starting treatment and for four weeks after each dose increase. NHS England's guidance on weight-management injections recommends adding a non-oral method of contraception during those windows. It's a practical, specific point, and exactly the kind of thing that needs to come from your clinical team, not a forum thread.
Dose-timing questions, what to do after a missed injection, and decisions about stopping treatment are all in the same category. The Patient Information Leaflet that comes with your pen covers the official guidance; your prescriber covers your individual picture. Those two sources, together, are the help that's actually designed for you.
Tirzepatide was developed as a weight-management and type 2 diabetes medicine, and that's what it's licensed for in the UK. But as more people have used it, questions have emerged about effects that weren't the primary focus of the clinical trials. Some patients have noticed changes in sleep quality, there's an honest look at what the evidence does and doesn't say about whether Mounjaro helps sleep. Others have asked about focus and attention; the question of whether Mounjaro affects ADHD symptoms is one our prescribers hear with increasing regularity, and the evidence is still early.
These are legitimate questions, and they deserve honest answers rather than dismissal. What they don't deserve is speculation dressed up as clinical advice. If you're noticing effects (positive or otherwise) beyond weight change, the right move is to log them and raise them with your prescriber at your next review. That's not bureaucracy; it's how medicine learns.
If you're at the stage of deciding whether Mounjaro is the right treatment for you at all, a broader overview of how Mounjaro works and who it's licensed for might be the more useful starting point, or you can compare it alongside other options on our weight-loss treatment overview.
One thing that puts people off online pharmacies is uncertainty about what happens after the first order. We designed nume, sorry, we designed our service specifically around the answer to that concern. Every consultation is read by a GPhC-registered Independent Prescriber the same day you submit it. Not an automated screening tool. Not a chatbot parsing your answers. A clinician reading them, the same day, every time.
A question our prescribers field most weeks: "Can I just email a quick question without doing a full review?" The answer is yes, our aftercare team is available seven days a week for exactly that. If something changes between your monthly pens, you don't have to wait for your next repeat order to raise it. That's what aftercare is for. You can find out more about how we operate and who oversees clinical decisions on our about us page, or read about our clinical lead's background on our prescriber profile page.
For questions about how Mounjaro helps with weight loss at a biological level, our page walks through what's actually happening in your body in detail. And if your real question is more personal ("will this actually work for me?") that's addressed more directly in our piece on what the evidence says for individual patients.
If you're ready to begin, a free consultation with our prescribers is the first step. Start your free consultation and have your answers reviewed the same day.
The people
Superintendent Pharmacist (GPhC No. 2217101)
Accountable for the safe running of our registered pharmacy, from every dispensing check to every dispatch.
Clinical Lead (GPhC No. 2231744)
Sets our clinical standards and checks everything we publish against current MHRA guidance.
Independent Prescriber (GPhC No. 2084501)
Personally reviews consultations and assesses whether treatment is clinically appropriate, and leads dose adjustments and follow-up checks.
Independent Prescriber (GPhC No. 2083426)
Personally reviews consultations and assesses whether treatment is clinically appropriate, and leads dose adjustments and follow-up checks.